002001
vs
Shanghai Composite
Over the past 12 months, has outperformed Shanghai Composite, delivering a return of 29% compared to the Shanghai Composite's 12% growth.
Stocks Performance
002001 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
|
US |
Eli Lilly and Co
NYSE:LLY
|
||
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
||
DK |
Novo Nordisk A/S
CSE:NOVO B
|
||
US |
Johnson & Johnson
NYSE:JNJ
|
||
US |
Merck & Co Inc
NYSE:MRK
|
||
CH |
Roche Holding AG
SIX:ROG
|
||
UK |
AstraZeneca PLC
LSE:AZN
|
||
CH |
Novartis AG
SIX:NOVN
|
||
US |
Pfizer Inc
NYSE:PFE
|
Performance Gap
002001 vs Shanghai Composite
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
|
US |
Eli Lilly and Co
NYSE:LLY
|
||
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
||
DK |
Novo Nordisk A/S
CSE:NOVO B
|
||
US |
Johnson & Johnson
NYSE:JNJ
|
||
US |
Merck & Co Inc
NYSE:MRK
|
||
CH |
Roche Holding AG
SIX:ROG
|
||
UK |
AstraZeneca PLC
LSE:AZN
|
||
CH |
Novartis AG
SIX:NOVN
|
||
US |
Pfizer Inc
NYSE:PFE
|
Performance By Year
002001 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
|
US |
Eli Lilly and Co
NYSE:LLY
|
||
UK |
Dechra Pharmaceuticals PLC
LSE:DPH
|
||
DK |
Novo Nordisk A/S
CSE:NOVO B
|
||
US |
Johnson & Johnson
NYSE:JNJ
|
||
US |
Merck & Co Inc
NYSE:MRK
|
||
CH |
Roche Holding AG
SIX:ROG
|
||
UK |
AstraZeneca PLC
LSE:AZN
|
||
CH |
Novartis AG
SIX:NOVN
|
||
US |
Pfizer Inc
NYSE:PFE
|
Competitors Performance
Zhejiang Nhu Co Ltd vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
|
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
Zhejiang Nhu Co Ltd
Glance View
Zhejiang Nhu Co Ltd. began its journey in the dynamic world of pharmaceuticals and chemicals, carving a niche for itself in a highly competitive market. Established in Zhejiang Province, China, the company quickly established a reputation for producing high-quality vitamins and nutraceutical ingredients. The precision and reliability of their manufacturing processes cater to various industries, from animal nutrition to human healthcare, standing as a testament to their commitment to excellence. Their state-of-the-art facilities and rigorous quality control have allowed them to expand their reach beyond domestic borders, tapping into the global market and serving an international clientele. At the heart of Zhejiang Nhu's business model is its ability to leverage cost-effective manufacturing to provide competitively priced products without compromising on quality. This approach not only ensures strong demand for their ingredients but also positions the company favorably against global competitors. By efficiently scaling their operations and investing in research and development, Zhejiang Nhu continuously enhances its product portfolio, thus creating multiple revenue streams. The company's strategic investments in technological innovation have paved the way for it to remain relevant and competitive, ensuring sustainable growth in an ever-evolving industry landscape.